These experiments showed that the cytotoxic effect of dronedarone was independent of and not altered by THRα or THRα1 knockdown in all cell lines tested; this finding provides evidence to support that THRα or THRα1 is not the target that mediates dronedarone’s anti-cancer effects. The gene discussed is THRA; the disease is cancer.